Taiwan Semiconductor Manufacturing Company heads into its October 15 Q3 results with short sellers largely absent, borrow costs drifting lower, and the market focused almost entirely on what the 2nm ramp means for forward revenue.
The lending market offers no drama. Availability is essentially unlimited, shares to borrow vastly exceed any demand, and borrow costs have been falling. At 0.54%, the cost to borrow is down 11% on the week and 23% over the past month, back near the low end of its recent range after a brief mid-September spike toward 0.85%. Short interest itself is negligible relative to the float, and the ORTEX short score of 25.3 ranks in the 96th percentile for "friendliness to the stock," meaning very little of the free float is being pressed by shorts. There is no squeeze dynamic, no borrow stress, and no sign that conviction against the stock is building.
The Street's positioning reflects the same confidence, at least in aggregate. The valuation picture shows a trailing P/E of 18.5 and EV/EBITDA of 12.4, both drifting modestly higher over the past month alongside the stock's 2.3% gain in September. The EV/EBITDA multiple has actually eased slightly on the week, suggesting the market is absorbing the share price gain without meaningfully re-rating the business. Factor scores lean heavily in TSMC's favour: the dividend rank hits the 99th percentile, days-to-cover ranks at the 89th, and EV/EBIT sits at the 74th. Formal analyst data is too stale to cite. The most recent price targets on file are from early 2021 and cannot be reconciled with a TWD 2,475 stock trading on the Taiwan exchange.
Institutional ownership reinforces the sense of entrenched, long-term conviction. The National Development Fund holds 6.4% and has not moved its position. Capital Research added roughly 8.5 million shares to sit at 5.1%. Vanguard Capital added 9.7 million, BlackRock 15.3 million. These are incremental additions at the margin, but the direction is uniformly positive among the top four holders, all of whom reported positions as recently as August. The co-COO received a stock grant in September covering 32,000 shares; the CFO received 20,000. These are compensation events, not open-market buys, but the scale of the grant round signals standard retention activity at the senior level.
Earnings history warrants a note of caution. The July 2026 Q2 print saw the stock fall 6.1% on the day, with a further partial recovery leaving it down about 1.4% over the following five sessions. That was the most recent print. Before drawing comfort from the 2nm demand narrative, it is worth remembering that TSMC has delivered at least one sharp negative day-one reaction in recent quarters, even when fundamentals were constructive.
The monthly revenue data filed with the Taiwan Stock Exchange covers the company's own figures through August, but the dataset has not yet accumulated enough history to test whether it leads the quarterly print. It is colour for now, not a leading indicator.
With Q3 results 15 days away, the question is no longer whether the 2nm ramp is real. It is whether the market's expectation of that ramp is already priced into a stock that has gained 48% year-to-date on the New York-listed ADR. The gap between a strong operational update and a positive price reaction has narrowed as the share price has risen, and the July earnings reaction is a reminder that good results and good stock performance on results day are not the same thing.
See the live data behind this article on ORTEX.
Open 2330 on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
